IDEAYA Biosciences (IDYA) Operating Margin (2020 - 2026)
IDEAYA Biosciences (IDYA) reported Operating Margin of 1654.63% for Q1 2026, down 90.29% sequentially from 869.53% in Q4 2025.
IDEAYA Biosciences (IDYA) Operating Margin (2020 - 2026) Analysis & Trends
IDEAYA Biosciences (IDYA) has 7 years of Operating Margin data on file, last reported at 1654.63% in Q1 2026.
- For the quarter ending Q1 2026, Operating Margin changed N/A year-over-year to 1654.63%; the trailing twelve-month figure through Mar 2026 stood at 78.99% (changed N/A YoY), and the FY2025 full-year result was 72.84%, up 459823.0% from the prior year.
- Operating Margin fell to 1654.63% in Q1 2026, from 869.53% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 52.18% in Q3 2025 to a low of 2059.11% in Q4 2024.
- A 5-year average of 703.2% and a median of 537.28% in 2022 frame the typical range for Operating Margin.
- Across the five-year window, Operating Margin plunged 99035 bps in 2024 and surged 118959 bps in 2025, its largest moves.
- Tracing IDYA's Operating Margin over 5 years: stood at 657.46% in 2022, then sank by 63 bps to 1068.77% in 2023, then slumped by 93 bps to 2059.11% in 2024, then surged by 58 bps to 869.53% in 2025, then tumbled by 90 bps to 1654.63% in 2026.
- Business Quant data shows IDYA's Operating Margin at 1654.63% in Q1 2026, 869.53% in Q4 2025, and 52.18% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | IDEAYA Biosciences | 3.21 Bn | 2.54 Bn | - | -1,654.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,654.63% |
| Dec 31, 2025 | -869.53% |
| Sep 30, 2025 | 52.18% |
| Dec 31, 2024 | -2,059.11% |
| Dec 31, 2023 | -1,068.77% |
| Sep 30, 2023 | -417.09% |
| Jun 30, 2023 | -922.94% |
| Mar 31, 2023 | -333.49% |
| Dec 31, 2022 | -657.46% |
| Sep 30, 2022 | 2.22% |
| Jun 30, 2022 | -384.53% |
| Mar 31, 2022 | -125.19% |
| Dec 31, 2021 | -620.16% |
| Sep 30, 2021 | -130.49% |
| Jun 30, 2021 | -126.21% |
| Mar 31, 2021 | -126.05% |
| Dec 31, 2020 | -49.95% |
| Sep 30, 2020 | -55.72% |